$17.05
$0.58
(3.52%)
Quote as of 4:00 PM EST on 02/09/12
Amylin Pharmaceuticals, Inc.
NASDAQ:AMLN
Extended Hours:
$16.67
-$0.38
(-2.23%)
Quote as of 4:10 PM EST on 02/09/12 (NASDAQ)
|
$17.05
$0.58
(3.52%)
|
|
| Today's Open | $15.68 |
|---|---|
| Previous Close | $16.47 |
| Daily Range | $15.60 - $17.10 |
| 52-Week Range | $8.03 - $18.30 |
| Market Cap | $2.49B |
| P/E Ratio | 183.00 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 5,447,796 |
| Average Daily Volume | 4,548,588 |
| Current FY EPS | -$1.27 |
AMLN Information
| Description |
|---|
| A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
5 of Last Week's Biggest Winners
The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and
Novo Nordisk Posts Solid 4Q - Analyst Blog
Revenues Skyrocket at Merged Alkermes - Analyst Blog
Amylin Pharmaceuticals Shares Popped Again: What You Need to Know
New Study for Alkermes' Vivitrol - Analyst Blog
Company News for January 31, 2012 - Corporate Summary
Zyprexa Pulls Down Lilly's 4Q Sales - Analyst Blog
